| 000 | 02456 a2200721 4500 | ||
|---|---|---|---|
| 005 | 20250516205343.0 | ||
| 264 | 0 | _c20151015 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a2567-689X | ||
| 024 | 7 |
_a10.1160/TH13-10-0874 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMayer, K | |
| 245 | 0 | 0 |
_aA comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry. _h[electronic resource] |
| 260 |
_bThrombosis and haemostasis _cAug 2014 |
||
| 300 |
_a342-51 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 |
_aCoronary Thrombosis _xetiology |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aDrug Substitution |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xadverse effects |
| 650 | 0 | 4 |
_aPiperazines _xadverse effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aPlatelet Function Tests |
| 650 | 0 | 4 | _aPrasugrel Hydrochloride |
| 650 | 0 | 4 | _aPrecision Medicine |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPurinergic P2Y Receptor Antagonists _xadverse effects |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2Y12 _xblood |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThiophenes _xadverse effects |
| 650 | 0 | 4 |
_aTiclopidine _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSchulz, S | |
| 700 | 1 | _aBernlochner, I | |
| 700 | 1 | _aMorath, T | |
| 700 | 1 | _aBraun, S | |
| 700 | 1 | _aHausleiter, J | |
| 700 | 1 | _aMassberg, S | |
| 700 | 1 | _aSchunkert, H | |
| 700 | 1 | _aLaugwitz, K-L | |
| 700 | 1 | _aKastrati, A | |
| 700 | 1 | _aSibbing, D | |
| 773 | 0 |
_tThrombosis and haemostasis _gvol. 112 _gno. 2 _gp. 342-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1160/TH13-10-0874 _zAvailable from publisher's website |
| 999 |
_c23723824 _d23723824 |
||